Imipenem/Cilastatin/Relebactam (MK-7655A) Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia (MK-7655A-016)

PHASE3CompletedINTERVENTIONAL
Enrollment

274

Participants

Timeline

Start Date

September 18, 2018

Primary Completion Date

July 12, 2022

Study Completion Date

July 12, 2022

Conditions
Hospital-Acquired Bacterial PneumoniaVentilator-Associated Bacterial Pneumonia
Interventions
DRUG

IMI/REL FDC

500 mg Imipenem, 500 mg Cilastatin and 250 mg Relebactam powder FDC provided in a single vial

DRUG

PIP/TAZ FDC

4000 mg Piperacillin and 500 mg Tazobactam powder FDC provided in a single vial

DRUG

Linezolid

Open-label 600 mg Linezolid

Trial Locations (68)

1012

Mary Johnston Hospital ( Site 0901), Metro Manila

1104

Lung Center of the Philippines ( Site 0903), Quezon City

5000

West Visayas State University Medical Center ( Site 0900), Iloilo City

36000

Reg. Clin. Hospital ( Site 1306), Poltava

44093

CHU de Nantes - Hotel Dieu ( Site 0600), Nantes

44280

Hospital Civil de Guadalajara Fray Antonio Alcalde ( Site 0800), Guadalajara

44340

Hospital Civil Nuevo de Guadalajara Dr. Juan I. Menchaca ( Site 0804), Guadalajara

49006

ME Dnipropetrovsk Clinical Joinder of Emergency Care of DRC ( Site 1304), Dnipro

59037

Hopital Roger Salengro du Lille ( Site 0601), Lille

61124

City Clinical Hospital No13 of Kharkiv City Council ( Site 1303), Kharkiv

69495

Hospices Civils de Lyon ( Site 0603), Pierre-Bénite

76008

Ivano-Frankivsk regional clinical hospital ( Site 1301), Ivano-Frankivsk

94270

Hopital Bicetre ( Site 0605), Le Kremlin-Bicêtre

100020

Beijing Chaoyang Hospital ( Site 0126), Beijing

100034

Peking University First Hospital ( Site 0131), Beijing

100049

Aero Space center hospital ( Site 0118), Beijing

100073

The Seventh Medical Center of PLA General Hospital-Intensive medicine ( Site 0157), Beijing

100191

Peking University Third Hospital ( Site 0115), Beijing

100730

Beijing Hospital ( Site 0127), Beijing

110001

The First Affiliated Hospital of China Medical University ( Site 0116), Shenyang

163001

First City Clinical Hospital n.a. E.E.Volosevich ( Site 1016), Arkhangelsk

164500

City Hospital #2 Severodvinsk ( Site 1017), Severodvinsk

192242

Research Institute of Emergency Medicine n.a. I.I.Dzhanelidze ( Site 1011), Saint Petersburg

194291

Clinical Hospital #122 L.G. Sokolova FMBA ( Site 1015), Saint Petersburg

196247

City Hospital #26 ( Site 1002), Saint Petersburg

200025

Ruijin Hospital Shanghai Jiao Tong University School of Medicine ( Site 0104), Shanghai

200040

Huadong Hospital Affiliated Fudan University ( Site 0103), Shanghai

Huashan Hospital of Fudan University ( Site 0105), Shanghai

200080

Shanghai General Hospital ( Site 0125), Shanghai

200443

Shanghai Pulmonary Hospital ( Site 0108), Shanghai

212000

Affiliated Hospital of Jiangsu University ( Site 0147), Zhenjiang

213003

The First People's Hospital of Changzhou ( Site 0139), Changzhou

214023

Wuxi People's Hospital ( Site 0124), Wuxi

215008

First Hospital Affiliated to Suzhou University ( Site 0111), Suzhou

223300

First Huai'an Hospital Affiliated to Nanjing Medical University-Neurosurgery Department ( Site 0153), Huai'an

252000

People's Hospital of Liaocheng City-Neurology ( Site 0154), Liaocheng

300052

Tianjin Medical University General Hospital ( Site 0113), Tianjin

300723

Spitalul Clinic Judetean de Urgenta Pius Branzeu ( Site 1103), Timișoara

310003

The First Affiliated Hospital.Zhejiang University ( Site 0102), Hangzhou

310016

Sir Run Run Shaw Hospital School of Medicine Zhejiang University ( Site 0110), Hangzhou

315010

Ningbo First Hospital-neurosurgery ( Site 0152), Ningbo

323000

People s Hospital of Lishui City ( Site 0137), Lishui

325000

The 2nd Affiliated Hospital of Wenzhou Medical University ( Site 0130), Wenzhou

330006

Jiangxi Provincial People's Hospital ( Site 0129), Nanchang

The First Affiliated Hospital of Nanchang University ( Site 0132), Nanchang

The Second Affiliated Hospital of Nanchang University-Neurosurgery Department ( Site 0151), Nanchang

350005

The First Affiliated Hospital Of Fujian Medical University-Respiratory ( Site 0136), Fuzhou

361004

Zhongshan Hospital Affiliated to Xiamen University ( Site 0133), Xiamen

363000

Zhangzhou Municipal Hospital of Fujian Province-Neurosurgery Department ( Site 0150), Zhangzhou

410004

Changsha Central Hospital ( Site 0119), Changsha

410005

Hunan Provincial People Hospital ( Site 0122), Changsha

442000

Shiyan City People's Hospital-Neurosurgery ( Site 0155), Shiyan

450052

The First Affiliated Hospital of Zhengzhou University ( Site 0121), Zhengzhou

510080

The First Affiliated Hospital ( Site 0100), Guangzhou

510120

The First Affiliated Hospital of Guangzhou Medical University ( Site 0123), Guangzhou

510180

Guangzhou First People's Hospital ( Site 0101), Guangzhou

510280

Zhujiang Hospital of Southern Medical University ( Site 0148), Guangzhou

510515

Southern Medical University Nanfang Hospital ( Site 0120), Guangzhou

518020

Shenzhen People s Hospital ( Site 0134), Shenzhen

530022

The first people s hospital of Nanning ( Site 0138), Nanning

The first people s hospital of Nanning ( Site 0141), Nanning

570311

Hainan General Hospital ( Site 0106), Haikou

750004

General Hospital of Ningxia Medical University ( Site 0135), Yinchuan

30150-221

Santa Casa de Misericordia de Belo Horizonte ( Site 0300), Belo Horizonte

15090-000

Hospital de Base de Sao Jose de Rio Preto ( Site 0301), Sao Jose Do Rio Preto - SP

Unknown

Huizhou Municipal Central Hospital ( Site 0140), Huizhou

041915

Spitalul Clinic de Urgenta Bagdasar-Arseni ( Site 1101), Bucharest

01133

Kiyv city municipal hospital 17 ( Site 1300), Kiev

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT03583333 - Imipenem/Cilastatin/Relebactam (MK-7655A) Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia (MK-7655A-016) | Biotech Hunter | Biotech Hunter